Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and supports satiety signaling. It is commonly studied for appetite control, glucose regulation, insulin response, and weight-management models.
Tried Retatrutide after reading about the triple-agonist mechanism. Interesting compound. Results in our lab have been consistent so far.

